NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

BSGM

Biosig Technologies Inc

Jul 03 • 04:00PM ET

10.41

Dollar change +0.76
Percentage change 7.88	%

Healthcare • Medical Devices • USA • NASD

Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.62	Insider Own	39.71%	Shs Outstand	24.25M	Perf Week	22.33%
Market Cap	284.14M	Forward P/E	-	EPS next Y	-0.17	Insider Trans	0.00%	Shs Float	16.46M	Perf Month	62.15%
Enterprise Value	280.60M	PEG	-	EPS next Q	-0.04	Inst Own	27.68%	Short Float	7.90%	Perf Quarter	1892.73%
Income	-9.79M	P/S	9471.33	EPS this Y	66.67%	Inst Trans	8.13%	Short Ratio	1.68	Perf Half Y	700.77%
Sales	0.03M	P/B	96.90	EPS next Y	32.00%	ROA	-324.29%	Short Interest	1.30M	Perf YTD	598.66%
Book/sh	0.11	P/C	76.18	EPS next 5Y	-	ROE	-8041.70%	52W High	9.83 5.90%	Perf Year	2874.29%
Cash/sh	0.14	P/FCF	-	EPS past 3/5Y	57.17% 46.11%	ROIC	-361.25%	52W Low	0.23 4426.09%	Perf 3Y	50.46%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-55.07% -	Gross Margin	-403.85%	Volatility	18.73% 18.71%	Perf 5Y	-84.91%
Dividend TTM	-	EV/Sales	9353.33	EPS Y/Y TTM	80.60%	Oper. Margin	-47726.92%	ATR (14)	1.15	Perf 10Y	-82.65%
Dividend Ex-Date	-	Quick Ratio	2.37	Sales Y/Y TTM	-3.70%	Profit Margin	-37653.85%	RSI (14)	72.36	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.37	EPS Q/Q	62.27%	SMA20	41.05%	Beta	1.67	Target Price	10.00
Payout	-	Debt/Eq	0.02	Sales Q/Q	-100.00%	SMA50	119.55%	Rel Volume	0.93	Prev Close	9.65
Employees	5	LT Debt/Eq	0.00	Earnings	May 19	SMA200	441.77%	Avg Volume	775.77K	Price	10.41
IPO	Oct 30, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	-180.00% -	Trades		Volume	720,631	Change	7.88%

Jun-09-25 10:30AM	BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors (GlobeNewswire) -14.05%
Jun-04-25 08:25AM	BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor (GlobeNewswire) -10.59%
May-28-25 06:45PM	CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO) (GlobeNewswire) -8.74% -13.68%
01:46PM	BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (GlobeNewswire)
01:07PM	Streamex and BioSig Announce the Successful Closing of Share Exchange Transaction and Executive Leadership Changes Bringing a First-Mover Real World Asset Tokenization Company to the Nasdaq (GlobeNewswire)
08:20AM	Loading…
May-27-25 08:20AM	BioSig Technologies signs definitive share exchange agreement with Streamex (TipRanks) +21.40%
May-26-25 12:42PM	BioSig Stock Surges Following Share Exchange Deal With Streamex (Zacks)
May-25-25 06:31PM	BioSig Technologies, Inc. (BSGM) Turns to Tokenization with Streamex Acquisition (Insider Monkey)
May-23-25 07:56PM	BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain. (GlobeNewswire) +24.24% +21.40%
May-05-25 09:42AM	BioSig Enters into an LOI to Merge with Streamex Exchange Corp. (GlobeNewswire) +5.84%
08:30AM	BioSig Enters into an LOI to Merge with Streamex Exchange Corp. Creating a Publicly Listed Real-World Asset Tokenization Company Led by Seasoned Industry Executives (GlobeNewswire)
Apr-24-25 12:00PM	Biosig Technologies (BSGM) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) +31.25%
Mar-26-25 09:00AM	BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market (GlobeNewswire) +11.36%
Jan-22-25 07:00AM	OTC Markets Group Announces Quarterly Index Performance and Rebalancing (GlobeNewswire)
Nov-13-24 03:14PM	BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement (GlobeNewswire) -11.62%
03:13PM	Loading…
Oct-22-24 03:13PM	BioSig Technologies Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel (GlobeNewswire) +34.03%
Aug-01-24 04:32AM	BioSig intends to acquire Neuro-Kinesis assets (Medical Device Network)
Jul-31-24 09:45AM	BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation (GlobeNewswire)
Jul-25-24 01:57PM	BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024 (GlobeNewswire) -9.95%

BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Los Angeles, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSGM

Biosig Technologies Inc

Upgrade your FINVIZ experience